For 25 years, Mr. Dzwonczyk has successfully represented multinational companies as lead counsel in trials and appeals of patent cases in District Courts and at the Federal Circuit, as well as Section 337 cases at the International Trade Commission. His experience has encompassed technical areas that include recombinantly produced hormones, pharmaceuticals, protein synthesis and expression products, fibers, films, polymers, plastics and medical devices. Mr. Dzwonczyk also counsels clients on intellectual property issues, including validity and infringement of intellectual property rights, licensing and contract matters and Hatch-Waxman issues.
He has lectured on numerous topics including strategies for opinion drafting, pharmaceutical litigation strategies, AIA procedures, compulsory licensing, and Patent Law Reform. He is the former Chair of FCBA's amicus committee, a former member of its Board of Directors, as well as a former Chair of the AIPLA Chemical Practice Committee. Prior to working as a patent attorney, Mr. Dzwonczyk worked at FMC Corporation agricultural chemicals research facility on the synthesis, isolation and characterization of novel plant growth regulators, herbicides and insecticides.
Mr. Dzwonczyk is an adjunct professor of law at George Washington University's National Law Center, where he co-teaches International and Comparative Patent Law. He has been quoted by The Washington Post, The Legal Times, The Corporate Legal Times, Bloomberg News Service, The IP Law Bulletin, and others.
He was named in the 2014 IAM Patent 1000 list of The World’s Leading Patent Practitioners, and described as a leading expert in the 2014 Financier Worldwide Corporate Advisor Handbook for Intellectual Property.